Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cencora, Inc.COR · Entity 2994 | EVP & Chief Strategy Officer | June 28, 2024 | July 05, 2024 |
| Keenova Therapeutics plcNONE · Entity 28960 | Director | July 15, 2026 | July 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cencora, Inc.
Report date June 28, 2024 · Filed July 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,524.728 |
Reported balance
After 2024-06-28 transaction · row 1
1 source rowRow 1 · 2024-06-28 · Grant · Acquired 66.879 · Balance 9,524.728 F1: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c).
Keenova Therapeutics plc
Report date July 15, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,390 |
Reported balance
After 2026-07-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 4,406 · Balance 8,390 F1: Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU. F2: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU.
F2: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 18, 2026 01:56 UTC | Keenova Therapeutics plc NONE · Entity 28960 | GrantRestricted Stock Units · Derivative | 4,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084776 · tm2620763-9_4seq1.xml · derivative · entry 1 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,390 Underlying: Ordinary Shares · 4,406 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU. F2 · derivative.exercise_date: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. F2 · derivative.expiration_date: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:11 UTC | Keenova Therapeutics plc NONE · Entity 28960 | Exercise / conversionRestricted Stock Units · Derivative | 4,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070521 · tm2616870-4_4seq1.xml · derivative · entry 2 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,984 Underlying: Ordinary Shares · 4,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU. F2 · derivative.exercise_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. F2 · derivative.expiration_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:11 UTC | Keenova Therapeutics plc NONE · Entity 28960 | Exercise / conversionOrdinary Shares | 4,882 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-070521 · tm2616870-4_4seq1.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU. Read SEC document |
| June 02, 2026 Filed Jul 18, 2026 01:54 UTC Amendment | Keenova Therapeutics plc NONE · Entity 28960 | Exercise / conversionRestricted Stock Units · Derivative | 2,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-084773 · tm2620763-8_4aseq1.xml · derivative · entry 4 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,984 Underlying: Ordinary Shares · 2,685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU. F4 · derivative.exercise_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. F4 · derivative.expiration_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. Read SEC document |
| June 02, 2026 Filed Jul 18, 2026 01:54 UTC Amendment | Keenova Therapeutics plc NONE · Entity 28960 | Disposition to issuerRestricted Stock Units · Derivative | 2,197 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-084773 · tm2620763-8_4aseq1.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,669 Underlying: Ordinary Shares · 2,197 shares Expires not disclosed F3 · derivative.exercise_price: The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest. F5 · price: The number of RSUs forfeited is based on a percentage. F4 · derivative.exercise_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. F4 · derivative.expiration_date: The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. Read SEC document |
| June 02, 2026 Filed Jul 18, 2026 01:54 UTC Amendment | Keenova Therapeutics plc NONE · Entity 28960 | Tax withholdingOrdinary Shares | 619 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-084773 · tm2620763-8_4aseq1.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,066 F2 · price: The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market. Read SEC document |
| June 02, 2026 Filed Jul 18, 2026 01:54 UTC Amendment | Keenova Therapeutics plc NONE · Entity 28960 | Exercise / conversionOrdinary Shares | 2,685 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-26-084773 · tm2620763-8_4aseq1.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,685 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 01:47 UTC | Keenova Therapeutics plc NONE · Entity 28960 | GrantRestricted Stock Units · Derivative | 3,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019922 · tm267115-2_4seq1.xml · derivative · entry 1 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,866 Underlying: Ordinary Shares · 3,984 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU. F2 · derivative.exercise_date: Each RSU will fully vest on February 23, 2027. F2 · derivative.expiration_date: Each RSU will fully vest on February 23, 2027. F3 · balance_after: Reflects that the Reporting Person received 820 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. ("Par Health") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health. Read SEC document |
| August 14, 2025 Filed Aug 19, 2025 01:02 UTC | Keenova Therapeutics plc NONE · Entity 28960 | GrantRestricted Stock Units · Derivative | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-079942 · tm2523680-2_4seq1.xml · derivative · entry 1 Donato Leslie E · CIK 0001784795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,062 Underlying: Ordinary Shares · 4,062 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit ("RSU") will be settled in ordinary shares of the Issuer at one share per RSU. F2 · derivative.exercise_date: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. F2 · derivative.expiration_date: The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,432 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:08 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 533 | $233.53 | $124,471.49 |
DisclosureSEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,457.849 Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:08 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-24-000105 · wk-form4_1719950905.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,990.849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| June 28, 2024 Filed Jul 5, 2024 20:13 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 66.879 | $191.51 | $12,807.66 |
DisclosureSEC source: 0001140859-24-000107 · wk-form4_1720210429.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,524.728 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| January 04, 2024 Filed Jan 8, 2024 21:09 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 40.097 | $174.57 | $6,999.85 |
DisclosureSEC source: 0001140859-24-000004 · wk-form4_1704748133.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,558.849 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 21:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 3,400 | $202.13 | $687,242.00 |
DisclosureSEC source: 0001140859-23-000217 · wk-form4_1703624417.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,518.752 Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:10 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 3,387 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-23-000187 · wk-form4_1700089817.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,387 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:10 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 3,387 | $197.60 | $669,271.20 |
DisclosureSEC source: 0001140859-23-000187 · wk-form4_1700089817.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,918.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| November 13, 2023 Filed Nov 15, 2023 23:10 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 3,387 | $86.09 | $291,586.83 |
DisclosureSEC source: 0001140859-23-000187 · wk-form4_1700089817.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,305.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,273 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · derivative · entry 6 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,274 Underlying: Common Stock · 1,273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F3 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. F3 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · derivative · entry 5 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. F1 · price: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. F1 · derivative.exercise_date: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. F1 · derivative.expiration_date: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 665 | $197.57 | $131,384.05 |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · nonDerivative · entry 4 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,918.752 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,273 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · nonDerivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,583.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 697 | $197.57 | $137,706.29 |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,310.752 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 10, 2023 Filed Nov 14, 2023 21:13 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000177 · wk-form4_1699996377.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,007.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Annual grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · derivative · entry 5 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,192 Underlying: Common Stock · 1,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. F3 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 573 | $196.82 | $112,777.86 |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · nonDerivative · entry 4 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,674.752 F4 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · nonDerivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,247.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/9/2023, 11/9/2024, and 11/9/2025. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | Tax withholdingCommon Stock | 5,250 | $179.97 | $944,842.50 |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,151.752 F2 · kind: Satisfaction of tax withholding obligation incident to the vesting of performance share units. Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | GrantCommon Stock | 10,052 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,401.752 F1 · price: Shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance share units. Read SEC document |
| November 08, 2023 Filed Nov 13, 2023 21:41 UTC | Cencora, Inc. COR · Entity 2994 | GrantRestricted Stock Units · Derivative | 3,049 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001140859-23-000165 · wk-form4_1699911670.xml · derivative · entry 6 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,049 Underlying: Common Stock · 3,049 shares Expires not disclosed F5 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F5 · price: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F5 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. F5 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vests in three equal installments on 11/08/2024, 11/08/2025, and 11/08/2026. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 20:03 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 3,386 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-23-000132 · wk-form4_1695412993.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,387 Underlying: Common Stock · 3,386 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 20:03 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 3,386 | $185.00 | $626,410.00 |
DisclosureSEC source: 0001140859-23-000132 · wk-form4_1695412993.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,349.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 21, 2023 Filed Sep 22, 2023 20:03 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 3,386 | $86.09 | $291,500.74 |
DisclosureSEC source: 0001140859-23-000132 · wk-form4_1695412993.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,735.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 1,845 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · derivative · entry 8 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,773 Underlying: Common Stock · 1,845 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 1,845 | $175.00 | $322,875.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 6 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,349.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 1,845 | $86.09 | $158,836.05 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 5 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,194.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 4,929 | $0.00 Strike: $86.09 | $0.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · derivative · entry 7 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,618 Underlying: Common Stock · 4,929 shares Expires 2026-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. F2 · derivative.exercise_date: Exercisable in four equal annual installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 4,929 | $175.00 | $862,575.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 4 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,349.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | Exercise / conversionCommon Stock | 4,929 | $86.09 | $424,337.61 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,278.752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 898 | $175.00 | $157,150.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,349.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| September 05, 2023 Filed Sep 7, 2023 20:00 UTC | Cencora, Inc. COR · Entity 2994 | SaleCommon Stock | 888 | $175.00 | $155,400.00 |
DisclosureSEC source: 0001140859-23-000128 · wk-form4_1694116810.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,247.752 F1 · shares: The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person dated May 26, 2023. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,432 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000102 · wk-form4_1688414735.xml · derivative · entry 3 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,432 Underlying: Common Stock · 1,432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F1 · derivative.exercise_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. F1 · derivative.expiration_date: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 534 | $192.43 | $102,757.62 |
DisclosureSEC source: 0001140859-23-000102 · wk-form4_1688414735.xml · nonDerivative · entry 2 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,048.631 Read SEC document |
| July 01, 2023 Filed Jul 3, 2023 20:05 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionCommon Stock | 1,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001140859-23-000102 · wk-form4_1688414735.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,582.631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Grant of restricted stock units received for no consideration that vest in three equal annual installments on July 1, 2022, July 1, 2023, and July 1, 2024. Read SEC document |
| June 30, 2023 Filed Jul 10, 2023 20:11 UTC | Cencora, Inc. ABC · Entity 2994 | GrantCommon Stock | 87.121 | $163.57 | $14,250.03 |
DisclosureSEC source: 0001140859-23-000104 · wk-form4_1689019895.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,135.752 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c). Read SEC document |
| December 30, 2022 Filed Jan 18, 2023 21:11 UTC | Cencora, Inc. ABC · Entity 2994 | GrantCommon Stock | 96.664 | $140.85 | $13,615.51 |
DisclosureSEC source: 0001140859-23-000013 · wf-form4_167407627598789.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,150.631 F1 · shares: Purchase of common stock through the Employee Stock Purchase Plan exempt under Rule 16b-3(c) and Rule 16b-3(d). Read SEC document |
| December 22, 2022 Filed Dec 23, 2022 21:04 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 930 | $170.00 | $158,100.00 |
DisclosureSEC source: 0001140859-22-000121 · wf-form4_167182944312326.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,053.967 Read SEC document |
| December 09, 2022 Filed Dec 12, 2022 21:20 UTC | Cencora, Inc. ABC · Entity 2994 | SaleCommon Stock | 3,014 | $166.12 | $500,685.68 |
DisclosureSEC source: 0001140859-22-000100 · wf-form4_167088000999414.xml · nonDerivative · entry 1 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,983.967 Read SEC document |
| November 13, 2022 Filed Nov 14, 2022 23:55 UTC | Cencora, Inc. ABC · Entity 2994 | Exercise / conversionRestricted Stock Units · Derivative | 1,743 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001140859-22-000086 · wf-form4_166847007956132.xml · derivative · entry 11 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,743 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units received for no consideration that vest 100% on 11/13/2022. F6 · price: Restricted stock units received for no consideration that vest 100% on 11/13/2022. F6 · derivative.exercise_date: Restricted stock units received for no consideration that vest 100% on 11/13/2022. F6 · derivative.expiration_date: Restricted stock units received for no consideration that vest 100% on 11/13/2022. Read SEC document |
| November 13, 2022 Filed Nov 14, 2022 23:55 UTC | Cencora, Inc. ABC · Entity 2994 | Tax withholdingCommon Stock | 911 | $153.01 | $139,392.11 |
DisclosureSEC source: 0001140859-22-000086 · wf-form4_166847007956132.xml · nonDerivative · entry 8 Donato Leslie E · CIK 0001784795 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,997.967 F4 · kind: Satisfaction of tax withholding obligation incident to the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.